ChemicalBook > CAS DataBase List > Idarucizumab
Idarucizumab
- Product Name
- Idarucizumab
- CAS No.
- 1362509-93-0
- Chemical Name
- Idarucizumab
- Synonyms
- Research Grade Idarucizumab;Research Grade Idarucizumab (DGK09701)
- CBNumber
- CB63039317
- Formula Weight
- 0
- MOL File
- Mol file
More
Less
Idarucizumab Chemical Properties,Usage,Production
Uses
Idarucizumab is a humanized monoclonal antibody fragment. Idarucizumab is first reversal agent for a direct oral anticoagulant (DOAC). Idarucizumab can specifically neutralize the effects of the oral direct thrombin inhibitor in order to restore hemostasis[1].
References
[1] Finks SW, et al. Idarucizumab (Praxbind): The First Reversal Agent for a Direct Oral Anticoagulant. Am J Med. 2017 May;130(5):e195-e197. DOI:10.1016/j.amjmed.2016.11.029
Idarucizumab Preparation Products And Raw materials
Raw materials
Preparation Products
More
Less
Idarucizumab Suppliers
- Tel
- 177-54423994 17754423994
- Fax
- QQ:2853530913
- 2853530910@QQ.com
- Country
- China
- ProdList
- 8000
- Advantage
- 62
- Tel
- 027-65317797 15926423062
- Fax
- QQ:422450190
- 422450190@qq.com
- Country
- China
- ProdList
- 10308
- Advantage
- 58
- Tel
- 027-65279366 18108604356
- products@biolabreagent.com
- Country
- China
- ProdList
- 9868
- Advantage
- 58
- Tel
- 13720134139 086-15871494362 13720134139
- orders@jknbiochem.com
- Country
- China
- ProdList
- 6762
- Advantage
- 58
- Tel
- 021-65675885 18964387627
- customer_service@efebio.com
- Country
- China
- ProdList
- 11973
- Advantage
- 58
- Tel
- 0731-13823398 15111215862
- 313359644@qq.com
- Country
- China
- ProdList
- 4161
- Advantage
- 58
- Tel
- 17316404525 17316404525
- 209533805@qq.com
- Country
- China
- ProdList
- 9763
- Advantage
- 58
- Tel
- 027-87008169 17762441161
- info@atagenix.com
- Country
- China
- ProdList
- 10001
- Advantage
- 58
- Tel
- 33175446423
- support@antibodysystem.com
- Country
- China
- ProdList
- 6739
- Advantage
- 58
- Tel
- 51288865780
- sales@biosynth.com
- Country
- China
- ProdList
- 6051
- Advantage
- 58
1362509-93-0, IdarucizumabRelated Search:
Mipasetamab
Osocimab
Dapirolizumab Pegol
Lacutamab
Lilotomab
Talacotuzumab
Minretumomab [inn]
Vepsitamab
Galegenimab
Lorvotuzumab Mertansine